• Home
  • Search
  • Integrated transcriptomic analysis reveals a CEBPB–DUSP1 axis driving tumor progression in colorectal cancer
  • https://doi.org/10.1371/journal.pone.0337892Copy DOI Icon

Integrated transcriptomic analysis reveals a CEBPB–DUSP1 axis driving tumor progression in colorectal cancer

  • Dec 18, 2025
  • PLOS One
  • Huarong Zhou +1 more
Show More
  • Abstract
  • Literature Map
  • References
  • Similar Papers
Abstract

Colorectal cancer (CRC) is a prevalent and lethal malignancy, yet the transcriptional networks driving its progression remain incompletely defined. Here, we used integrated transcriptomic analyses of healthy and colorectal cancer samples from three datasets—TCGA-COAD, GSE100179 and GSE196006, and laboratory assays to uncover CCAAT/enhancer-binding protein beta (CEBPB) as a key driver of CRC. Elevated CEBPB expression in clinical samples correlated with shorter overall survival, suggesting its utility as a prognostic marker. We next identified DUSP1, a dual specificity phosphatase critical for MAPK regulation, as a direct transcriptional target of CEBPB. Motif enrichment and promoter scans revealed three high-affinity CEBPB-binding sites in the DUSP1 promoter. Luciferase reporter assays confirmed that CEBPB directly modulates DUSP1 transcription. Knockdown of CEBPB in HCT116 cells rescued DUSP1 expression and reduced pro-tumor pathways linked to hyperactive MAPK. The resulting phenotype showed decreased cell proliferation, enhanced apoptosis, and partial reversion of the malignant features typically associated with CRC. These findings underscore that CEBPB–DUSP1 dysregulation contributes to CRC aggressiveness, influencing both inflammatory and metabolic processes. Overall, this work highlights CEBPB as a potential biomarker for poor prognosis and points to the CEBPB–DUSP1 axis as a promising therapeutic target. Our findings also demonstrate the power of integrated transcriptomic approaches in elucidating intricate gene regulatory networks, offering a basis for new strategies to mitigate CRC progression.

Similar Papers
  • Research Article

Abstract 5131: Dysregulated cholesterol metabolism facilitates epithelial-to-mesenchymal transition and tumor progression in colorectal cancer

  • Apr 21, 2025
  • Cancer Research
  • Blake M Arciga +3
  • Research Article
  • Citations3

Stromal-cell-derived Factor 1-α Promotes Tumor Progression in Colorectal Cancer

  • Feb 01, 2012
  • Journal of the Korean Society of Coloproctology
  • Se Jun Park +10
  • Research Article

Abstract 34: The receptor for hyaluronan acid mediator motility (RHAMM, CD168) expression in EMT-like cancer cells is a predictor of tumor progression in colorectal cancer

  • Sep 30, 2014
  • Cancer Research
  • Valentina Mele +9
  • Research Article
  • Citations16

Steroid receptor RNA activator gene footprint in the progression and drug resistance of colorectal cancer through oxidative phosphorylation pathway

  • Sep 11, 2021
  • Life Sciences
  • Mohammad Mahdevar +9
  • Research Article
  • Citations2

Analysis of tumor-associated macrophages' heterogeneity in colorectal cancer patients using single-cell RNA-seq data.

  • Feb 01, 2022
  • Journal of Clinical Oncology
  • Yulia Innokenteva Nussbaum +4
  • Research Article
  • Citations36

Long non‑coding RNA 00152 functions as a competing endogenous RNA to regulate NRP1 expression by sponging with miRNA‑206 in colorectal cancer.

  • Jun 22, 2018
  • International journal of oncology
  • Zhuan-Peng Chen +9
  • Research Article
  • Citations1

Joint Analysis of CCAAT/Enhancer-Binding Protein Beta and Interleukin 1 Beta in the Treatment and Prognosis of Diffuse Large B-Cell Lymphoma.

  • Oct 30, 2024
  • Frontiers in bioscience (Landmark edition)
  • Hongmin Wang +10
  • Research Article

Multi-omics Approaches to CCAAT/Enhancer-Binding Protein Beta in Oral Squamous Cell Carcinoma: Crosstalk Between Tumor Cells and Tumor-Associated Macrophages Driving Disease Progression.

  • Sep 18, 2025
  • Current cancer drug targets
  • Min Li +7
  • PDF
  • Research Article
  • Citations80

HERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer

  • Nov 25, 2013
  • Scientific Reports
  • Olivia Crociani +14
  • Research Article

Abstract 1061: Clinico-pathological significance of LINE-1 and ESR1 methylation levels in sporadic colorectal cancer

  • Aug 01, 2015
  • Cancer Research
  • Tomofumi Noguchi +14
  • Research Article
  • Citations3

Integrative epitranscriptomic and transcriptomic characterization in human colorectal cancer.

  • Sep 01, 2025
  • Journal of advanced research
  • Ting Gong +23
  • Research Article
  • Citations16

The downregulation of Rap1 GTPase-activating protein is associated with a poor prognosis in colorectal cancer and may impact on tumor progression.

  • Mar 20, 2018
  • Oncology Letters
  • Wei‑Li Gao +3
  • Research Article
  • Citations28

Differential expression of ST6GAL1 in the tumor progression of colorectal cancer

  • Apr 01, 2017
  • Biochemical and Biophysical Research Communications
  • Sen Zhang +15
  • Research Article

Immunoexpression of metalloproteinase 14 and tissue inhibitor of metalloproteinase 2 in colorectal carcinomas and lymph node metastases

  • Mar 13, 2015
  • Comparative Clinical Pathology
  • Francisco Nélson Nóbrega Furtado +6
  • Research Article
  • Citations24

Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer

  • Aug 01, 2012
  • Hepatobiliary & Pancreatic Diseases International
  • Wei Cui +4
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.